SCHEMBL6564562

SCHEMBL6564562

OC(c1ccc(C(F)(F)F)cc1)c1ccccc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.49
TOP2B Q02880 1/20 0.49
HDAC4 P56524 2/20 0.45
ACP3 P15309 1/20 0.44
EEF2K O00418 1/20 0.43
CES2 O00748 2/20 0.42
CES1 P23141 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
NCOR2 Q9Y618 1/20 0.42
HSD11B1 P28845 1/20 0.42
PDE2A O00408 3/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566037 0.81 CES2 (0.43) HDAC4CES2CES1IDO1TDO2
SCHEMBL30910940 0.81 CES2 (0.43) HDAC4CES2CES1IDO1TDO2
SCHEMBL30986702 0.81 CES2 (0.43) HDAC4CES2CES1IDO1TDO2
SCHEMBL11854191 0.81 TOP2A (0.48) TOP2ATOP2BHDAC4ACP3CES2
SCHEMBL6564729 0.81 TOP2A (0.48) TOP2ATOP2BACP3CES2CES1
SCHEMBL477718 0.81 IDO1 (0.50) CES2CES1IDO1TDO2ADORA2A
SCHEMBL30910884 0.81 IDO1 (0.50) CES2CES1IDO1TDO2ADORA2A
SCHEMBL30986701 0.81 IDO1 (0.50) CES2CES1IDO1TDO2ADORA2A
SCHEMBL3858520 0.81 IDO1 (0.50) CES2CES1IDO1TDO2ADORA2A
SCHEMBL477694 0.79 ACP3 (0.59) TOP2ATOP2BACP3CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 TOP2A 3424/4885TOP2B 2538/4885HDAC4 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.